The global cGAS-STING Pathway Market is expanding as pharmaceutical and biotechnology companies increase investment in immune-modulating therapies designed to achieve more controlled pathway activation across oncology and inflammatory disease applications. According to Future Market Insights (FMI), the market is projected to grow from USD 2.5 billion in 2026 to USD 8.2 billion by 2036,...